Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04942 | 33442446 | World J Hepatol | Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. | 2020 | Details |
| A04952 | 33439074 | Aging Male | Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study. | 2021 | Details |
| A04957 | 33437902 | Hepatol Commun | Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis. | 2020 | Details |
| A04962 | 33437731 | Med J Islam Repub Iran | Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients. | 2020 | Details |
| A04967 | 33435558 | Molecules | Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice. | 2021 | Details |
| A04969 | 33435415 | Diagnostics (Basel) | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. | 2021 | Details |
| A04982 | 33426569 | J Med Syst | Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. | 2021 | Details |
| A04985 | 33425804 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. | 2020 | Details |
| A04989 | 33422644 | Mol Metab | Neonatal overfeeding during lactation rapidly and permanently misaligns the hepatic circadian rhythm and programmes adult NAFLD. | 2021 | Details |
| A04994 | 33421884 | Eur J Radiol | The clinical utility of accurate NAFLD ultrasound grading: Results from a community-based, prospective cohort study. | 2021 | Details |
| A05007 | 33413363 | Cardiovasc Diabetol | Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. | 2021 | Details |
| A05016 | 33409407 | Transl Gastroenterol Hepatol | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis. | 2021 | Details |
| A05038 | 33398223 | J Clin Exp Hepatol | Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? | 2020 | Details |
| A05041 | 33397230 | Curr Pharm Des | Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease. | 2021 | Details |
| A05046 | 33395640 | Georgian Med News | [PROGNOSIS ASSESSMENT OF THE COMBINED COURSE OF STABLE CORONARY HEART DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS AFTER REVASCULARIZATION INTERVENTIONS]. | 2020 | Details |
| A05052 | 33392801 | Curr Atheroscler Rep | Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel? | 2021 | Details |
| A05053 | 33392241 | Front Nutr | The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)-A Systematic Review and Meta-Analysis. | 2020 | Details |
| A05072 | 33387670 | Clin Gastroenterol Hepatol | The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants. | 2020 | Details |
| A05108 | 33373113 | Liver Int | The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. | 2021 | Details |
| A05116 | 33370454 | J Gastroenterol Hepatol | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes. | 2021 | Details |
| A05149 | 33354557 | Can J Gastroenterol Hepatol | Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients. | 2020 | Details |
| A05166 | 33348045 | Clin Gastroenterol Hepatol | Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study. | 2020 | Details |
| A05172 | 33346905 | Protein Cell | The role of the gut microbiome and its metabolites in metabolic diseases. | 2020 | Details |
| A05184 | 33343673 | Evid Based Complement Alternat Med | Investigation of the Synergistic Effect of Brown Sugar, Longan, Ginger, and Jujube (Brown Sugar Longan Ginger Tea) on Antioxidation and Anti-Inflammation in In Vitro Models. | 2020 | Details |
| A05194 | 33340925 | Thromb Res | Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. | 2020 | Details |
| A05210 | 33337654 | Cardiol Rev | Part 1: Disease of the Heart and Liver: A Relationship That Cuts Both Ways. | 2022 | Details |
| A05213 | 33336648 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. | 2020 | Details |
| A05223 | 33333240 | Respir Physiol Neurobiol | Functional foods from the tropics to relieve chronic normobaric hypoxia. | 2020 | Details |
| A05240 | 33327438 | Int J Mol Sci | Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05263 | 33320193 | Endocrinology | The Importance of Keeping Time in the Liver. | 2021 | Details |
| A05274 | 33317243 | Clin Mol Hepatol | Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. | 2020 | Details |
| A05282 | 33313020 | Can J Gastroenterol Hepatol | Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: "Un Affaire de Coeur". | 2020 | Details |
| A05288 | 33311949 | World J Gastroenterol | Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome. | 2020 | Details |
| A05298 | 33309070 | Clin Investig Arterioscler | Approach to the cardiometabolic continuum. Narrative description. | 2020 | Details |
| A05307 | 33307021 | Gastroenterology | AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A05322 | 33302841 | Curr Hypertens Rev | Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver. | 2021 | Details |
| A05325 | 33302598 | Int J Mol Sci | Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. | 2020 | Details |
| A05340 | 33296704 | Diabetes Metab | NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. | 2020 | Details |
| A05342 | 33294831 | JHEP Rep | Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease. | 2020 | Details |
| A05354 | 33285128 | Am J Med | Life's Simple 7 and Nonalcoholic Fatty Liver Disease: The Multiethnic Study of Atherosclerosis. | 2020 | Details |
| A05372 | 33279947 | Eur J Clin Nutr | Lipid and saturated fatty acids intake and cardiovascular risk factors of obese children and adolescents. | 2020 | Details |
| A05373 | 33279452 | Clin Res Hepatol Gastroenterol | Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients. | 2020 | Details |
| A05389 | 33273916 | Int J Endocrinol | Follicle-Stimulating Hormone Positively Associates with Metabolic Factors in Perimenopausal Women. | 2020 | Details |
| A05395 | 33271878 | Cells | Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools. | 2020 | Details |
| A05406 | 33269025 | J Med Biochem | Is endocan a novel potential biomarker of liver steatosis and fibrosis? | 2020 | Details |
| A05407 | 33269017 | J Med Biochem | Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis. | 2020 | Details |
| A05446 | 33253736 | Int J Cardiol | Sudden cardiac death following liver transplantation: Incidence, trends and risk predictors. | 2020 | Details |
| A05452 | 33251981 | Acta Chir Belg | Combined liver transplantation and off-pump coronary artery bypass grafting: a report of two cases. | 2020 | Details |
| A05462 | 33248947 | Arch Biochem Biophys | The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD. | 2020 | Details |
| A05470 | 33248065 | Metabolism | Functions of amyloid precursor protein in metabolic diseases. | 2020 | Details |
| A05481 | 33240906 | Front Med (Lausanne) | CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver. | 2020 | Details |
| A05490 | 33235107 | Medicine (Baltimore) | Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China. | 2020 | Details |
| A05494 | 33234342 | Clin Nutr | Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study. | 2020 | Details |
| A05495 | 33233601 | Diagnostics (Basel) | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis. | 2020 | Details |
| A05501 | 33228237 | Int J Mol Sci | Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease. | 2020 | Details |
| A05507 | 33224584 | Am J Cardiovasc Dis | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis. | 2020 | Details |
| A05526 | 33218301 | BMC Fam Pract | Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association? | 2020 | Details |
| A05562 | 33205261 | Curr Gastroenterol Rep | Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope? | 2020 | Details |
| A05572 | 33203192 | Metabolites | Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. | 2020 | Details |
| A05581 | 33200507 | J Diabetes | Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study. | 2020 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05594 | 33195636 | World J Clin Cases | Relationship between non-alcoholic fatty liver disease and coronary heart disease. | 2020 | Details |
| A05610 | 33190175 | Obes Surg | Development and Validation of a Predictive Model of Success in Bariatric Surgery. | 2020 | Details |
| A05615 | 33187255 | Cells | Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence. | 2020 | Details |
| A05619 | 33186403 | PLoS One | Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. | 2020 | Details |
| A05637 | 33179890 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. | 2020 | Details |
| A05640 | 33178812 | Ann Transl Med | Diabetes and carotid artery disease: a narrative review. | 2020 | Details |
| A05653 | 33171865 | Diagnostics (Basel) | Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs. | 2020 | Details |
| A05658 | 33170809 | JCI Insight | Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans. | 2020 | Details |
| A05667 | 33166436 | Arch Endocrinol Metab | Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05679 | 33162743 | Ann Gastroenterol | Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A05683 | 33160101 | Mol Metab | Genetic and epigenetic factors determining NAFLD risk. | 2020 | Details |
| A05686 | 33158299 | Nutrients | Investigating Whether the Mediterranean Dietary Pattern Is Integrated in Routine Dietetic Practice for Management of Chronic Conditions: A National Survey of Dietitians. | 2020 | Details |
| A05695 | 33152943 | Biomed Pharmacother | The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. | 2020 | Details |
| A05703 | 33149804 | Oxid Med Cell Longev | Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05706 | 33148171 | BMC Gastroenterol | Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease. | 2020 | Details |
| A05716 | 33144054 | Dig Liver Dis | Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population. | 2020 | Details |
| A05725 | 33142714 | J Clin Med | Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis. | 2020 | Details |
| A05767 | 33126575 | Nutrients | Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. | 2020 | Details |
| A05769 | 33126411 | Cells | The Role of PPARs in Disease. | 2020 | Details |
| A05772 | 33125745 | Hepatology | Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. | 2021 | Details |
| A05789 | 33116724 | Diabetes Metab Syndr Obes | Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome. | 2020 | Details |
| A05795 | 33114564 | Nutrients | Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation. | 2020 | Details |
| A05799 | 33114290 | Int J Mol Sci | The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection. | 2020 | Details |
| A05802 | 33114148 | Int J Mol Sci | Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. | 2020 | Details |
| A05814 | 33110139 | Sci Rep | Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05818 | 33108366 | PLoS One | Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. | 2020 | Details |
| A05827 | 33105679 | Genes (Basel) | Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study. | 2020 | Details |
| A05830 | 33104787 | Phys Ther | Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions. | 2021 | Details |
| A05835 | 33102800 | Endocrinol Diabetes Metab | Perspectives on youth-onset nonalcoholic fatty liver disease. | 2020 | Details |
| A05840 | 33102794 | Endocrinol Diabetes Metab | The metabolic basis of nonalcoholic steatohepatitis. | 2020 | Details |
| A05847 | 33102495 | Front Med (Lausanne) | miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. | 2020 | Details |
| A05850 | 33102138 | Toxicol Rep | Welding fume inhalation exposure and high-fat diet change lipid homeostasis in rat liver. | 2020 | Details |
| A05852 | 33101480 | Exp Ther Med | Prediction of NAFLD occurrence in prediabetes patients. | 2020 | Details |
| A05870 | 33094956 | Clin Transl Gastroenterol | Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05872 | 33093663 | Nat Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. | 2020 | Details |
| A05879 | 33091191 | Hepatol Res | Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A structured review of published works. | 2020 | Details |
| A05904 | 33080603 | Digestion | Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH. | 2020 | Details |
| A05931 | 33072455 | Cureus | Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2020 | Details |